In the search to lower out-of-pocket costs for prescription drugs, consumers will encounter a number of different coupons, discounts and assistance programs available to them. They don't all work the ...

The Patient Assistance solutions ensure patients receive their medications, even if alternative funding is unavailable or they don’t qualify for need-based assistance.

Some employers are tapping into dollars provided through patient financial assistance initiatives set up by drugmakers.

Some insurers and employers are tapping into assistance programs meant for individual patients. The concern: Some costly drugs could be harder for patients to access.

Takeaway Points This literature review focuses on the impact of patient assistance programs and outcomes. The findings include the following: Some evidence of a positive association between co-pay ...

Michael Kolodziej, MD: So, the currently available patient assistance programs, offered by either pharmaceutical companies directly or through third parties, have some benefits, and they have some ...

How do I apply for the Restasis patient assistance program? To apply for Medicare’s Restasis patient assistance program, you’ll need to fill out an application. Review the participation terms ...

DexCom, Inc., the leader in continuous glucose monitoring systems for people with diabetes, announced today a new patient assistance program to aid current U.S. customers who have lost insurance ...

FDA approves Leqembi Iqlik as a weekly subcutaneous injection for Alzheimer's treatment, enhancing patient convenience and ...

In the rapidly evolving landscape of healthcare, Pharma Patient Assistance Programs (PAP) have been a lifeline for many patients seeking access to essential medications. These programs aim to help ...

Before the change, families whose household income was equal to or less than 300% of the federal poverty guidelines were eligible for Norton Healthcare's financial assistance program.

Some insurers and employers are tapping into assistance programs meant for individual patients. The concern: Some costly drugs could be harder for patients to access.